DIAGNOS Q3 2022 Financial Statements
DIAGNOS Q3 2022 Financial Statements
DIAGNOS Q3 2022 Financial Statements 1
DIAGNOS Q3 2022 Financial Statements 1
DIAGNOS Announces Closing of Private Placement and New Marketing Director 1
DIAGNOS Announces Closing of Private Placement and New Marketing Director 1
Le Réseau de santé CAN et DIAGNOS du Québec annoncent un partenariat pour un programme de dépistage de la rétinopathie diabétique qui change la vie
Le RВseau de santВ CAN et DIAGNOS du QuВbec annoncent un partenariat pour un programme de dВpistage de la rВtinopathie diabВtique qui change la vie
CAN Health Network and Quebec Based DIAGNOS Announce Life Changing Diabetic Retinopathy Screening Program Partnership
CAN Health Network and Quebec Based DIAGNOS Announce Life Changing Diabetic Retinopathy Screening Program Partnership
DIAGNOS annonce la signature dun contrat avec Farmacias Benavides un membre de Walgreens Boots Alliance au Mexique
DIAGNOS annonce la signature dun contrat avec Farmacias Benavides un membre de Walgreens Boots Alliance au Mexique
DIAGNOS annonce le déploiement de son application de détection de la dégénérescence maculaire liée à l’âge dans les cliniques d’optométrie d’IRIS Le Groupe Visuel
DIAGNOS Annonce le DВploiement de son Application de DВtection de la DВgВnВrescence Maculaire LiВe Е l╢ge dans les Cliniques dOptomВtrie dIRIS Le Groupe Visuel
DIAGNOS announces the start of the deployment of its pathology detection systems in the retail clinics of Farmacias Benavides
DIAGNOS announces the start of the deployment of its pathology detection systems in the retail clinics of Farmacias Benavides
DIAGNOS Announces the deployment of its Age Related Macular Degeneration detection application into the optometry clinics of IRIS The Visual Group
DIAGNOS Announces the deployment of its Age Related Macular Degeneration detection application into the optometry clinics of IRIS The Visual Group
DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
